The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
02/01/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
W81XWH-09-ARP-IDEA
Opportunity Category:
Discretionary
Posted Date:
Feb 01, 2009
Creation Date:
Feb 01, 2009
Original Closing Date for Applications:
Jul 22, 2009
Current Closing Date for Applications:
Jul 22, 2009
Archive Date:
Aug 21, 2009
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
7
Estimated Total Program Funding:
$3,900,000
Award Ceiling:
Award Floor:
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The ARP Idea Award supports high-impact, innovative research that advances the understanding of ASD and leads to improved quality of life for individuals with ASD. The Idea Award is designed to promote new ideas; therefore, proposals need not include preliminary data. Areas of Interest (Revised for FY09): While this award mechanism seeks applications from all areas of basic, translational, clinical, behavioral, and epidemiological ASD research, the FY09 ARP encourages applications that address critical needs of the autism community in the following areas:
• Co-morbidity: (e.g., manifestations such as disorders [gastrointestinal, sleep, behavioral, speech/language], psychiatric, seizures, immune dysfunction, motor and sensory deficits, metabolic dysfunction, and effects of ASD on intellectual ability)
• Predictors for Treatment Outcome: Identification of biomarkers, clinical characteristics, or other phenotypic markers that predict outcomes of a treatment (traditional or complementary and alternative), or populations that will or will not respond to a treatment.
Link to Full Announcement
If you have difficulty accessing the full announcement
electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP Help Desk
Synopsis Modification History
There are currently no modifications for this opportunity.